The immunosuppressive drug cyclosporin A (CsA) has shown antiparasitic activity against several protozoans and helminths, when complexed to proteins called cyclophilins (CyPs). In this paper, the molecular characterisation of one member of the CyP family in Trypanosoma cruzi is reported. TcCyP19 gene proved to be highly conserved compared to CyPs from other organisms and was highly homologous to a Trypanosoma brucei brucei CyPA. This gene was expressed in Escherichia coli and the purified recombinant protein exhibited a peptidyl prolyl cis-trans isomerase activity that was inhibited by CsA (IC 50 = 18.4 þ 0.8 nM). The TcCyP19 gene was located on two chromosomal bands in T. cruzi CL Brener clone. ß
Introduction
Cyclosporin A (CsA) is an antifungal cyclic undecapeptide well known as an immunosuppressive agent and its antiparasitic e¡ect has been demonstrated against several protozoans and helminths (reviewed in [1] ). The immunosuppressive e¡ects of CsA are mediated by the binding to cyclophilins (CyPs) [2] , which are proteins highly conserved in all organisms studied to date [3] . CyPs catalyse the isomerisation of peptidyl proline bonds (prolyl peptidyl cis-trans isomerase (PPIase) activity) and mediate certain protein folding events [4] . CsA strongly inhibits the PPIase activity of the CyPs [5] . The immunosuppressive e¡ect of the CyP^CsA complex is exerted by the inhibition of the activity of the Ca 2 -dependent calcineurin [6] which blocks transcription factors necessary for expression of several lymphokine genes during T cell activation.
In Trypanosoma cruzi, the causative agent of the American trypanosomiasis or Chagas' disease, the e¡ects of CsA have been demonstrated in mice, where it exacerbated the infection in the acute phase due to its immunosuppressive properties [7] but showed no e¡ects in chronic infections [8] . The addition of CsA into the culture medium inhibited the growth of epimastigotes in vitro [7] . Nonimmunosuppressive CsA analogues have also shown antiparasitic activity in other parasites [1] and we were therefore interested in investigating whether T. cruzi CyPs could act as possible targets for these agents (CsA and the non-immunosuppressive CsA analogues), as a way of searching for new therapeutic drugs. No T. cruzi CyP has so far been characterised except for a protein possessing PPIase activity described as a FK506 binding protein, homologous to a macrophage infectivity potentiator [9] and with no sequence homology to CyPs.
The T. cruzi genome project is continuously providing information about new genes that will certainly contribute to parasite control. The expressed sequence tag (EST) projects have generated several thousands of new genes [10, 11] and cDNAs clones with sequence homologies to CyPs were selected for further characterisation. In this paper we describe the molecular characterisation of the TcCyP19 gene, one member of the CyP gene family in T. cruzi. This gene was expressed and we demonstrated that nanomolar concentrations of the immunosuppressive agent CsA clearly a¡ected the PPIase enzymatic activity catalysed by this T. cruzi CyP.
Materials and methods

cDNA clones
cDNA clones were derived from a T. cruzi CL Brener cDNA library previously constructed [12] and sequenced [10, 11] . The following cDNA clones, with their accession numbers in brackets, encoded the TcCyP19 gene: TENU0559 (AI021872), TENU1241 (AI046155), TENU1547
(AI053382), TENU1715 (AI053286), TENU3939 (AI110383), TENU0315 (AI005683) and TENU4889 (AW330143).
DNA sequencing
cDNA clone plasmids were puri¢ed from Escherichia coli using Wizard minipreps kits (Promega, USA). Both DNA strands were sequenced with Big Dye £uorescent terminator kit (Perkin Elmer) according to the manufacturer's protocols. Reactions were loaded on an automated sequencer ABI 377 (Perkin Elmer). Chromatograms were analysed and sequences were aligned using the DNA Bio-Edit software [13] . Analysis of sequence homologies was performed using the NCBI Blast server (http://www. ncbi.nlm.nih.gov/blast) [14] .
Expression and puri¢cation of T. cruzi CyP19 gene
The entire coding region of TENU0559 DNA clone was ampli¢ed using speci¢c sense (5P-GGATCCATGTCGTA-CAAGCCG) and antisense (5P-GGATCCCAGTTTAA-AGTTGACC) primers. PCR was performed using PFU DNA Polymerase (Promega, USA) and PCR products were digested with BamHI enzyme. Puri¢ed fragments were cloned into pQE30 plasmid (Qiagen, USA) and E. coli M15 strain was transformed. Recombinant colony plasmids were sequenced and recombinant bacteria were grown at 37³C to an OD 600 of 0.8. Addition of 1 mM isopropyl-L-D-thiogalactopyranoside induced the expression of TcCyP19 protein that was puri¢ed by a Ni 2 -nitriloacetate agarose column. Cloning, expression and protein puri¢cation were performed following Qiagen's protocols. Puri¢ed protein fractions were pooled, dialysed against 50 mM HEPES pH 7.5, 10% v/v glycerol, and quanti¢ed by Bradford's method [15] . SDS^PAGE on 12.5% acrylamide gels was performed in the Mini-Protean system (Bio-Rad) using standard conditions.
Assay of PPIase activity of TcCyP19 expressed protein
Progress of chymotryptic cleavage of N-succinyl-Ala-Ala-Pro-Phe-p-nitroanilide (N-suc-AAPF-pNA) (Sigma, USA) in the activity assays was monitored by measuring A 390 on a Uvidec 340 (Jasco, Japan) spectrophotometer essentially as described [16] . The enzymatic activity was initiated by adding 75 WM N-suc-AAPF-pNA as substrate to 1 ml assay mixture containing 35 mM HEPES, 100 mM NaCl bu¡er, pH 7.9, 50 nM puri¢ed expressed TcCyP19 protein and 100 Wg K-chymotrypsin to cleave the chromogenic p-nitroanilide. Reactions were performed at 20³C. No recombinant protein was added in control samples.
CsA inhibition assays
The e¡ect of CsA on PPIase activity was analysed by incubating 50 nM of puri¢ed TcCyP19 with di¡erent concentrations of CsA diluted in ethanol, ranging from 0 to 1000 nM, for 2 min at 20³C. The reaction was then initiated as described above. Experiments were performed in duplicate.
Pulsed ¢eld gel electrophoresis (PFGE) analysis
Chromosomes from T. cruzi CL Brener clone were separated by PFGE using di¡erent run conditions [17] and transferred to nylon ¢lters (kindly given by Mario Galindo, Instituto de Ciencias Biomëdicas, Facultad de Medicina, Universidad de Chile). Schizosaccharomyces pombe and Saccharomyces cerevisiae chromosomes were used as markers (Bio-Rad, USA). cDNAs were PCR-ampli¢ed and DNA product was puri¢ed with PCR Concert columns (Gibco, BRL, USA). Probes were labelled with [K-32 P]dCTP by random priming (Prime a gene, Promega, USA) and DNA hybridisations were performed in SSC 6U, Denhardt solution 5U, SDS 0.5% and salmon sperm DNA 50 Wg ml 31 , overnight at 65³C. Washes were performed in SSC 1U, SDS 0.1%, for 30 min at 65³C and SSC 0.1U, SDS 0.1%, for 15 min, at 65³C, followed by exposure to X-ray ¢lms.
Results and discussion
Sequence analysis of TcCyP19 gene
We found seven T. cruzi cDNA clones containing overlapping sequences homologous to CyPAs from other organisms. Some other ADNc sequenced in the T. cruzi genome project also showed homology to other CyP isoforms, but the ESTs encoding TcCyP19 gene seemed to be more abundant than other CyPs in T. cruzi at least at the mRNA level in the epimastigote stage.
The largest clone TENU0559 with a 1019-bp insert contained an open reading frame encoding a putative protein of 177 amino acids. The deduced amino acid sequence corresponded to a protein with a theoretical molecular mass of 18.782 and this gene was hence designated TcCyP19. Upon comparison to public data bases using BLASTX software [14] the TcCyP19 protein showed to be highly homologous to the Trypanosoma brucei brucei CyPA (U68270) with a sequence similarity of 81% but also to other parasite CyPs with similarity values ranging between 79% and 81%. A sequence comparison of this T. cruzi CyP to the T. brucei brucei, Leishmania major and Trypanosoma vivax CyPA is shown in Fig. 1 . The T. cruzi CyP sequence showed a high conservation of the essential residues involved in the enzymatic activity and in the binding to CsA. It also shows the tryptophan residue considered essential for CsA binding [18] (Fig. 1 ).
Expression of TcCyP19 gene and PPIase activity
The TcCyP19 gene was expressed as a protein in E. coli and puri¢ed after a¤nity column to a single band of 24 kDa as assessed by SDS^PAGE (Fig. 2, lane 3) , though this recombinant protein should be around 21 kDa. Fig. 1 . Alignment of protozoan CyPs. Amino acid sequences were deduced from the cDNA sequences. TcCyP19 gene (GenBank1 accession number AF191832) was aligned to the sequences of T. brucei brucei CyPA (U68270), L. major CyP (Y13576.1), and T. vivax CyPA (U68269) using the BioEdit program [13] . The asterisks or (V) indicate the amino acids involved in CsA binding [21] or in the interaction with N-suc-AAPF-pNA substrate [22] , respectively. The # refers to the tryptophan residue critical for CsA binding [18] . TcCyP19 puri¢ed protein was tested for PPIase activity by following the cis-trans isomerisation of the substrate Nsuc-AAPF-pNA in a coupled reaction using K-chymotrypsin. The presence of 50 nM of the recombinant protein showed speci¢city for the trans Ala-Pro conformer of the substrate cleaving the chromogenic p-nitroanilide product, and signi¢cantly increased the yield of the chromogenic product compared to the absorbance registered without the recombinant protein.
CsA inhibition of TcCyP19 PPIase activity
To test the inhibitory e¡ect of the immunosuppressive drug CsA on the PPIase activity of the TcCyP19 recombinant protein, a di¡erent amount of CsA was preincubated with the TcCyP19 protein. As shown in Fig. 3 , CsA clearly a¡ected the rate of isomerisation catalysed by the T. cruzi CyP. CsA concentration from 100 nM up to 1 WM decreased the PPIase activity to the basal level observed in the absence of TcCyP19 expressed protein. To obtain a 50% inhibition of the TcCyP19 enzymatic activity, 18.4 þ 0.8 nM CsA was needed ( Fig. 3) , which is in good agreement with some IC 50 reported for other protozoan species [19, 20] .
TcCyP19 gene chromosomal localisation
T. cruzi CyP19 gene was localised to chromosomes from the CL Brene clone, separated by PFGE. Two chromosomal bands with sizes of approximately 2200 and 2000 kbp were hybridised (Fig. 4) , presumably two homologue chromosomes.
We have characterised one CyP isoform in T. cruzi selected among other larger genes with sequence homology to CyPs from other organisms. We demonstrated that the recombinant protein of this isoform exhibited a CsA sensitive PPIase activity. As CsA has shown to inhibit T. cruzi parasite growth in vitro, it is conceivable that this e¡ect is exerted partly via the interaction with TcCyP19. But it is also possible that some of the other isoforms of CyPs in the parasite might contribute to this growth inhibition, although TcCyP19 gene is the most represented in the normalised cDNA library. There is evidence that the Ca 2 -calmodulin-dependent phosphatase 2B, calcineurin, might be involved in the modulation of the antiparasitic and immunosuppressive e¡ects of CsA [6] . No calmodulindependent phosphatase has been described in T. cruzi so far, but two partial sequences encoding calcineurin subunit B are present in the GenBank1 dbEST, AI035170 and AA952380. Whether the TcCyP19^CsA complex is able to block calcineurin-mediated signal transduction in host T cells has to be further studied.
The biological functions of T. cruzi CyPs, their natural substrate and their role in host parasite relationship are still unclear. Studies on the interaction of CyPs with T. cruzi target molecules will shed some light to the understanding of pathogenesis of the intracellular parasitism. Furthermore, studies on this and other CyP isoforms activity and inhibition by CsA and CsA non-immunosuppressive analogues might contribute to the design of new trypanocidal drugs.
